Locations:
SearchAdvertisement
Understanding the role of patient sex may lead to personalized therapies
Extent of ablated tumor coverage is a significant prognostic factor
Rationale and status reports on mechanistically diverse strategies
No evidence of residual tumor or recurrence at 6.5 years of follow-up
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Why it should be considered more often
Individual tumor DNA may be key
Established lymphoma/leukemia therapy also targets glioma stem cells
Hyperthermia augments radiation therapy
Hypoxic induction of vasorin regulates Notch1 turnover
Cleveland Clinic offers an abundance of direct delivery trials
Advertisement
Advertisement